IHT Wealth Management LLC Raises Stake in Danaher Co. (NYSE:DHR)

IHT Wealth Management LLC boosted its position in Danaher Co. (NYSE:DHR – Get Rating) by 18.2% during the third quarter, Holdings Channel.com reports. The institutional investor owned 5,185 shares of the conglomerate’s stock after purchasing an additional 800 shares during the period. IHT Wealth Management LLC’s holdings in Danaher were worth $1,339,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of DHR. Moisand Fitzgerald Tamayo LLC boosted its position in Danaher by 5,850.0% in the 3rd quarter. Moisand Fitzgerald Tamayo LLC now owns 119 shares of the conglomerate’s stock worth $31,000 after purchasing an additional 117 shares in the last quarter. Bellwether Advisors LLC boosted its position in Danaher by 157.7% in the 3rd quarter. Bellwether Advisors LLC now owns 134 shares of the conglomerate’s stock worth $34,000 after purchasing an additional 82 shares in the last quarter. American National Bank boosted its position in Danaher by 31.9% in the 3rd quarter. American National Bank now owns 157 shares of the conglomerate’s stock worth $41,000 after purchasing an additional 38 shares in the last quarter. Veritas Investment Partners UK Ltd. purchased a new stake in Danaher in the 3rd quarter worth approximately $52,000. Finally, Valley National Advisers Inc. boosted its position in Danaher by 61.6% in the 3rd quarter. Valley National Advisers Inc. now owns 236 shares of the conglomerate’s stock worth $63,000 after purchasing an additional 90 shares in the last quarter. Hedge funds and other institutional investors own 77.26% of the company’s stock.

Insiders Place Their Bets

In other Danaher news, Director Raymond C. Stevens sold 8,410 shares of the firm’s stock in a transaction on Wednesday, January 25th. The stock was sold at an average price of $264.27, for a total value of $2,222,510.70. Following the completion of the sale, the director now directly owns 8,394 shares of the company’s stock, valued at approximately $2,218,282.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 11.20% of the company’s stock.

Analyst Ratings Changes

DHR has been the topic of several recent research reports. Barclays upped their price objective on Danaher from $277.00 to $290.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 24th. Cowen decreased their target price on Danaher from $340.00 to $320.00 and set an “outperform” rating on the stock in a research report on Wednesday, January 25th. StockNews.com began coverage on Danaher in a research report on Thursday. They set a “buy” rating on the stock. Robert W. Baird decreased their target price on Danaher from $321.00 to $309.00 in a research report on Wednesday, January 25th. Finally, Deutsche Bank Aktiengesellschaft began coverage on Danaher in a research report on Tuesday, December 13th. They set a “buy” rating and a $310.00 target price on the stock. Three equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $310.29.

Danaher Stock Up 3.0 %

NYSE DHR opened at $249.34 on Friday. The business has a fifty day moving average price of $258.67 and a 200 day moving average price of $262.63. Danaher Co. has a one year low of $233.71 and a one year high of $303.82. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.52 and a current ratio of 1.89. The company has a market cap of $181.66 billion, a P/E ratio of 25.84, a P/E/G ratio of 1.98 and a beta of 0.80.

Danaher (NYSE:DHR – Get Rating) last issued its earnings results on Tuesday, January 24th. The conglomerate reported $2.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.46 by $0.41. Danaher had a return on equity of 17.97% and a net margin of 22.91%. The business had revenue of $8.37 billion during the quarter, compared to the consensus estimate of $7.90 billion. During the same period last year, the company earned $2.69 EPS. The company’s revenue for the quarter was up 2.7% on a year-over-year basis. Research analysts anticipate that Danaher Co. will post 10.14 EPS for the current fiscal year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 28th. Shareholders of record on Friday, March 31st will be paid a $0.27 dividend. The ex-dividend date is Thursday, March 30th. This is an increase from Danaher’s previous quarterly dividend of $0.25. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.43%. Danaher’s dividend payout ratio (DPR) is 10.36%.

Danaher Company Profile

(Get Rating)

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services.